Germline mutations of TP53 gene in breast cancer-Reference-Cited by-同舟云学术

Germline mutations of TP53 gene in breast cancer

Published:2014-06-15 Issue:9 Volume:35 Page:9219-9227
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Damineni Surekha,Rao Vadlamudi Raghavendra,Kumar Satish,Ravuri Rajasekar Reddy,Kagitha Sailaja,Dunna Nageswara Rao,Digumarthi Raghunadharao,Satti Vishnupriya

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2176-6.pdf

Reference34 articles.

1. McBride OW, Merry D, Givol D. The gene for human TP53 cellular tumor antigene is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A. 1986;83:130–4.

2. Soussi T, Caron de Fomentel P. Structural aspects of the TP53 protein in relation to gene evolution. Oncogene. 1990;5:945–52.

3. Kristen K, Arnold J. Identification of a novel TP53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA. 1996;93(26):15335–40.

4. Cho Y, Gorina S, Jeffrey P, Pavletich NP. Crystal structure of a TP53 tumor suppressor DNA complex: understanding tumorigenic mutations. Science. 1994;265:346–55.

5. Hollestein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science. 1991;253:49–53.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery;Pharmaceuticals;2024-01-19

2. Potentilla nepalensis leaf extract revealed p53, Nf-kB1, and HSP proteins as biomarkers – Network Pharmacology, Molecular Docking and Dynamic studies;2023-11-09

3. Network pharmacology of Potentilla nepalensis extract revealed p53, Nf- kB1, and HSP proteins as potential biomarkers;2023-09-06

4. What Is Known about Breast Cancer in Young Women?;Cancers;2023-03-22

5. Role and Future Directions of PI3K Inhibitors in Cancer Treatment;Hans Journal of Medicinal Chemistry;2023